Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.

Grants from the National Institutes of Health come with additional money for overhead. A planned $4 billion cut would leave ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

The Trump administration recently removed heath data from government websites, which spurred a federal lawsuit filed Tuesday ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

A variety of pastries have been recalled due to listeria and salmonella concerns, according to the Food and Drug ...

The FDA announced the latest recall that includes approximately 2 million donuts from Dunkin’ and other brands, as well as ...

The FDA has set the second highest risk level for a nationwide baked goods recall—which includes some pastries sold at Dunkin ...

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...